Supreme Court Weighs Temporary Restriction Of Telehealth Access To Medical Abortion Pills
On May 1, the Fifth Circuit temporarily reinstated the pre-2023 in-person dispensing requirement for the chemical abortion pill mifepristone nationwide and blocked telehealth prescribing that allows residents in states with abortion bans to obtain the drugs in the mail. Danco Laboratories and GenBioPro immediately appealed the decision that would require anyone seeking chemical abortions to…Continue reading Supreme Court Weighs Temporary Restriction Of Telehealth Access To Medical Abortion Pills
